0001181431-12-002267.txt : 20120111 0001181431-12-002267.hdr.sgml : 20120111 20120111174104 ACCESSION NUMBER: 0001181431-12-002267 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120110 FILED AS OF DATE: 20120111 DATE AS OF CHANGE: 20120111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D CENTRAL INDEX KEY: 0001076979 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 12522777 MAIL ADDRESS: STREET 1: 18 CHERRYVILLE RD CITY: FLEMINGTON STATE: NJ ZIP: 08822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 rrd330437.xml KISHBAUCH 01.10.12 SALE X0304 4 2012-01-10 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001076979 KISHBAUCH MICHAEL D C/O ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511 1 1 0 0 CEO and President Common Stock 2012-01-10 4 M 0 90209 1.60 A 90209 D Common Stock 2012-01-10 4 S 0 90209 10.0149 D 0 D Common Stock 2012-01-11 4 M 0 8900 1.60 A 8900 D Common Stock 2012-01-11 4 S 0 8900 12.5021 D 0 D Employee Stock Option (Right to Buy) 1.60 2012-01-10 4 M 0 90209 0 D 2014-07-20 Common Stock 90209 90209 D Employee Stock Option (Right to Buy) 1.60 2012-01-11 4 M 0 8900 0 D 2014-07-20 Common Stock 8900 81309 D The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $10.00 to $10.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. This option was granted on July 20, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter. The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $12.50 to $12.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kishbauch on June 7, 2011. /s/ Michael Kishbauch 2012-01-11